Recent developments in the chemotherapeutic options for nonsmall cell lung cancerIBRAHIM, M. Nazir; ABDULLAH, Zarina; MARTIN, Michael J et al.Expert review of anticancer therapy. 2006, Vol 6, Num 10, pp 1397-1410, issn 1473-7140, 14 p.Article

First-and second-line therapy for advanced nonsmall cell lung cancerSCULIER, J-P; MORO-SIBILOT, D.The European respiratory journal. 2009, Vol 33, Num 4, pp 915-930, issn 0903-1936, 16 p.Article

His239Arg SNP of HRAD9 is associated with lung adenocarcinomaMANIWA, Yoshimasa; YOSHIMURA, Masahiro; BERMUDEZ, Vladimir P et al.Cancer. 2006, Vol 106, Num 5, pp 1117-1122, issn 0008-543X, 6 p.Article

Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinomaHAO CHANG; IIZASA, Toshihiko; SHIBUYA, Kiyoshi et al.Cancer. 2004, Vol 100, Num 8, pp 1665-1672, issn 0008-543X, 8 p.Article

Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohortSCOCCIANTI, Chiara; VESIN, Aurélien; MARTEL, Ghislaine et al.The European respiratory journal. 2012, Vol 40, Num 1, pp 177-184, issn 0903-1936, 8 p.Article

Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancerBERGHMANS, T; MEERT, A. P; MARTIN, B et al.The European respiratory journal. 2005, Vol 25, Num 2, pp 329-335, issn 0903-1936, 7 p.Article

EGCG Inhibits Transforming Growth Factor-β-Mediated Epithelial-to-Mesenchymal Transition via the Inhibition of Smad2 and Erkl/2 Signaling Pathways in Nonsmall Cell Lung Cancer CellsLIU, Liang-Chih; CHANG-YAOTSAO, Thomas; HSU, Shu-Rong et al.Journal of agricultural and food chemistry (Print). 2012, Vol 60, Num 39, pp 9863-9873, issn 0021-8561, 11 p.Article

Accumulation of hRad9 protein in the nuclei of nonsmall cell lung carcinoma cellsMANIWA, Yoshimasa; YOSHIMURA, Masahiro; BERMUDEZ, Vladimir P et al.Cancer. 2005, Vol 103, Num 1, pp 126-132, issn 0008-543X, 7 p.Article

Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinomaMARUYAMA, Riichiroh; SUGIO, Kenji; YOSHINO, Ichiro et al.Cancer. 2004, Vol 100, Num 7, pp 1472-1477, issn 0008-543X, 6 p.Article

A possible role for dihydrodiol dehydrogenase in the formation of benzo[a]pyrene-DNA adducts in lung cancer cells and tumor tissuesCHENG, Ya-Wen; TSAI, Horng-Jyh; WU, Jeng-Yuan et al.Environmental and molecular mutagenesis (Print). 2007, Vol 48, Num 1, pp 14-21, issn 0893-6692, 8 p.Article

Validation of the Lymph Node Ratio as a Prognostic Factor in Patients With N1 Nonsmall Cell Lung CancerJONNALAGADDA, Sirisha; ARCINEGA, Jacqueline; SMITH, Cardinale et al.Cancer. 2011, Vol 117, Num 20, pp 4724-4731, issn 0008-543X, 8 p.Article

Diagnosis of multiple primary lung cancer: A systematic reviewXINYING XUE; YUXIA LIU; LEI PAN et al.Journal of international medical research. 2013, Vol 41, Num 6, pp 1779-1787, issn 0300-0605, 9 p.Article

Is Sex Associated With the Outcome of Patients Treated With Radiation for Nonsmall Cell Lung Cancer?MCGOVERN, Susan L; ZHONGXING LIAO; KARA BUCCI, M et al.Cancer. 2009, Vol 115, Num 14, pp 3233-3242, issn 0008-543X, 10 p.Conference Paper

Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancerMOHAMED, Sherif; YASUFUKU, Kazuhiro; FUJISAWA, Takehiko et al.Cancer. 2007, Vol 109, Num 12, pp 2506-2514, issn 0008-543X, 9 p.Article

Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: The association between 1q amplification and tumor recurrenceTAI, Amy L. S; YAN, Wen-Sheng; YAN FANG et al.Cancer. 2004, Vol 100, Num 9, pp 1918-1927, issn 0008-543X, 10 p.Article

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3BORGET, I; CADRANEL, J; DANIEL, C et al.The European respiratory journal. 2012, Vol 39, Num 1, pp 172-179, issn 0903-1936, 8 p.Article

Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinomaROSENZWEIG, Kenneth E; FOX, Jana L; YORKE, Ellen et al.Cancer. 2005, Vol 103, Num 10, pp 2118-2127, issn 0008-543X, 10 p.Article

Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancerPELOSI, G; PASTORINO, U; BRESAOLA, E et al.British journal of cancer. 2003, Vol 88, Num 4, pp 537-547, issn 0007-0920, 11 p.Article

Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survivalSILVA, J; GARCIA, V; HERRERA, M et al.The European respiratory journal. 2011, Vol 37, Num 3, pp 617-623, issn 0903-1936, 7 p.Article

Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survivalOHRI, C. M; SHIKOTRA, A; GREEN, R. H et al.The European respiratory journal. 2009, Vol 33, Num 1, pp 118-126, issn 0903-1936, 9 p.Article

Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancerLIMING SHENG; MIN LUO; XIAOJIANG SUN et al.International journal of cancer (Print). 2013, Vol 133, Num 11, pp 2720-2725, issn 0020-7136, 6 p.Article

Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosisGOTTSCHLING, Sandra; JENSEN, Katrin; WARTH, Arne et al.The European respiratory journal. 2013, Vol 41, Num 3, pp 656-663, issn 0903-1936, 8 p.Article

Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement. CommentaryJANES, S. M; MCCAUGHAN, F; LARSEN, J. E et al.The European respiratory journal. 2007, Vol 30, Num 1, issn 0903-1936, 5-6, 21-25 [7 p.]Article

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patientsKRISTIANSEN, G; SCHLÜNS, K; YONGWEI, Y et al.British journal of cancer. 2003, Vol 88, Num 2, pp 231-236, issn 0007-0920, 6 p.Article

Activation of Mammalian Target of Rapamycin Pathway Confers Adverse Outcome in Nonsmall Cell Lung CarcinomaDAN LIU; YI HUANG; BOJIANG CHEN et al.Cancer. 2011, Vol 117, Num 16, pp 3763-3773, issn 0008-543X, 11 p.Article